within Pharmacolibrary.Drugs.V_Various.V03A_AllOtherTherapeuticProducts.V03AF11_ArginineAndLysine;

model ArginineAndLysine
  extends Pharmacolibrary.Drugs.ATC.V.V03AF11;

  annotation (Documentation(
info       = "<html><body><table><tr><td>Drug:</td><td>V03AF11</td></tr><td>route:</td><td>intravenous</td></tr><tr><td>n-compartments</td><td>1</td></tr></table><p>A combination of the amino acids L-arginine and L-lysine, primarily used to enhance renal uptake of radiolabelled somatostatin analogues during peptide receptor radionuclide therapy (PRRT) for neuroendocrine tumors. Administered as an adjunct to reduce radiation-induced nephrotoxicity. Approved as a supportive medical product for this application.</p><h4>Pharmacokinetics</h4><p>No published pharmacokinetic models reporting compartmental parameters for the combined arginine and lysine formulation in the clinical context of kidney protection during PRRT in adults; typical parameters are not reported in primary literature.</p><h4>References</h4><ol><li><p>Simell, O, et al., &amp; Eskelin, LE (1975). Lysinuric protein intolerance. <i>The American journal of medicine</i> 59(2) 229–240. DOI:<a href=\"https://doi.org/10.1016/0002-9343(75)90358-7\">10.1016/0002-9343(75)90358-7</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/1155480/\">https://pubmed.ncbi.nlm.nih.gov/1155480</a></p></li><li><p>Rolleman, EJ, et al., &amp; Krenning, EP (2003). Safe and effective inhibition of renal uptake of radiolabelled octreotide by a combination of lysine and arginine. <i>European journal of nuclear medicine and molecular imaging</i> 30(1) 9–15. DOI:<a href=\"https://doi.org/10.1007/s00259-002-0982-3\">10.1007/s00259-002-0982-3</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/12483404/\">https://pubmed.ncbi.nlm.nih.gov/12483404</a></p></li><li><p>Mahley, RW, et al., &amp; Holcombe, KS (1980). Inhibition of receptor-mediated clearance of lysine and arginine-modified lipoproteins from the plasma of rats and monkeys. <i>Proceedings of the National Academy of Sciences of the United States of America</i> 77(1) 225–229. DOI:<a href=\"https://doi.org/10.1073/pnas.77.1.225\">10.1073/pnas.77.1.225</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/6767236/\">https://pubmed.ncbi.nlm.nih.gov/6767236</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>",
    experiment (StartTime = 0, StopTime = 86400, Tolerance = 1e-9, Interval = 1)
  ));
end ArginineAndLysine;
